Extended-spectrum β-lactamases producing Enterobacteriaceae (ESBL-PE) prevalence in Nepal: A systematic review and meta-analysis

C Khadka, M Shyaula, G Syangtan, S Bista… - Science of The Total …, 2023 - Elsevier
An alarming increase in the occurrence of extended-spectrum β-lactamase-producing
Enterobacteriaceae (ESBL-PE) has threatened the treatment and management of bacterial …

[PDF][PDF] Molecular characterization of extended-spectrum beta-lactamases and carbapenemases producing Enterobacteriaceae isolated from North Eastern region of …

T Salvia, LS Singh, R Khati, K Ellappan… - Journal of Laboratory …, 2024 - researchgate.net
… Meta-analysis of proportion estimates of extended-spectrum-beta-lactamase producing
Enterobacteriaceae in East Africa hospitals. Antimicrob Resist Infect Control 2016;5:18. …

[HTML][HTML] Systematic surveillance and meta-analysis on the prevalence of metallo-β-lactamase producers among carbapenem resistant clinical isolates in Pakistan

N ul Ain, S Abrar, RAK Sherwani, A Hannan… - Journal of Global …, 2020 - Elsevier
… pathogens resistant to most broad spectrum antibiotics [1]. … were: Carbapenem resistance,
Metallo beta lactamases (MBLs), MBLs … Proportion estimates of Carbapenem resistant isolates …

… characterization of multidrug-resistant Klebsiella pneumoniaeand Escherichia coliharbouring extended spectrum beta-lactamases andcarbapenemases genes at a …

D Maina, G Revathi, AC Whitelaw - Microbiologia Medica, 2017 - ecommons.aku.edu
… Meta-analysis of proportion estimates of Extended-Spectrum-BetaLactamase-producing …
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid …

[PDF][PDF] Extended spectrum B-lactamase and plasmid mediated AmpC resistance in clinical isolates of escherichia coli from the central hospital of Maputo, Mozambique …

CEL Estaleva - 2016 - core.ac.uk
Extended spectrum β-Lactamase and plasmid mediated AmpC resistance in clinical … coli
producing extended spectrum β-lactamases in Kerman, Iran. Jundishapur J Microbiol 7: 1-7. 17. …

[HTML][HTML] Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) in healthcare and …

N Mannathoko, M Mosepele, R Gross, RM Smith… - International Journal of …, 2022 - Elsevier
… Multimodal interventions to prevent and control carbapenem-resistant Enterobacteriaceae
and extended-spectrum beta-lactamase producer-associated infections at a tertiary care …

Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: using diverse data to inform surveillance gaps

EA Mitgang, DM Hartley, MD Malchione, M Koch… - International journal of …, 2018 - Elsevier
… of patients (eg burns, oncology, transplantation) that typically have levels of resistance
higher than general acute-care populations were excluded from proportion estimates, as were …

Meta-analysis of proportion estimates of Extended-Spectrum-Beta-Lactamase-producing Enterobacteriaceae in East Africa hospitals.

T Sonda, H Kumburu, M van Zwetselaar… - Tropical Med Int …, 2017 - cmp.ku.dk
BACKGROUND: A high proportion of Extended-Spectrum-Beta-Lactamase (ESBL) producing
Enterobacteriaceae is causing common infections in all regions of the world. The burden …

[HTML][HTML] Extended-spectrum β-lactamase-producing gram-negative bacterial infections in severely ill COVID-19 patients admitted in a national referral hospital, Kenya

JM Mutua, JM Njeru, AM Musyoki - Annals of Clinical Microbiology and …, 2023 - Springer
… However, the impact on the epidemiology of extended-spectrum β-lactamases (ESBL), with
… ESBLs are a group of bacterial enzymes that hydrolyse expanded spectrum β-lactam, thus …

Antimicrobial Susceptibility Pattern and Detection of Extended-Spectrum Beta-Lactamase (blaCTX-M) Gene in Escherichia coli from Urinary Tract Infections at the …

E Chirwa, G Mulundu, K Ndashe, K Kanongesha… - medRxiv, 2020 - medrxiv.org
… The differences in ESBL proportion estimates maybe attributed to variations in populations
surveyed, difference in clinical diagnostic methods for UTIs, or by the levels of antibiotic use …